Literature DB >> 11425834

The use of misoprostol prior to hysteroscopy in postmenopausal women.

S W Ngai1, Y M Chan, P C Ho.   

Abstract

BACKGROUND: This study examined whether oral misoprostol exerted a cervical priming effect in postmenopausal women prior to hysteroscopy.
METHOD: Thirty-seven patients were randomized to receive either oral misoprostol (400 microg) or placebo (vitamin B(6)) 12 h prior to hysteroscopy. The resistance of the cervix to dilatation was objectively assessed by a cervical tonometer.
RESULTS: The mean baseline cervical dilatation (4.2 mm in misoprostol group versus 4.4 mm in placebo group) was similar between the two groups. The mean cumulative force measured (27.7 N in misoprostol group versus 21.8 N in placebo group) was also comparable. None of the patients suffered from any significant side-effects.
CONCLUSIONS: These data showed that there were no significant benefits from giving misoprostol pre-operatively in postmenopausal women, and it was concluded that oral misoprostol had no significant cervical priming effect in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425834     DOI: 10.1093/humrep/16.7.1486

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Intracervical versus vaginal misoprostol for cervical dilatation prior to operative hysteroscopy-a comparative study.

Authors:  Bk Goyal; Premansu Roy; Pm Bhat; Nk Das; Kg Paul; Bs Duggal
Journal:  Med J Armed Forces India       Date:  2012-04-21

2.  Vaginal Misoprostol for Cervical Priming before Gynaecological Procedures on Non Pregnant Women.

Authors:  Shyama Prasad Saha; Nabendu Bhattacharjee; Gangotri Baru
Journal:  Int J Health Sci (Qassim)       Date:  2007-07

3.  Uses of misoprostol in obstetrics and gynecology.

Authors:  Rebecca Allen; Barbara M O'Brien
Journal:  Rev Obstet Gynecol       Date:  2009

4.  A randomized trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women.

Authors:  Anita Kant; Usha Priyambada
Journal:  J Midlife Health       Date:  2011-01

5.  A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

6.  Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.

Authors:  K S Oppegaard; B-I Nesheim; O Istre; E Qvigstad
Journal:  BJOG       Date:  2008-01-16       Impact factor: 6.531

7.  Does self-administered vaginal misoprostol result in cervical ripening in postmenopausal women after 14 days of pre-treatment with estradiol? Trial protocol for a randomised, placebo-controlled sequential trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2008-06       Impact factor: 6.531

8.  Role of vaginal estradiol pretreatment combined with vaginal misoprostol for cervical ripening before operative hysteroscopy in postmenopausal women.

Authors:  Luisa Casadei; Eleonora Piccolo; Claudia Manicuti; Silvia Cardinale; Matteo Collamarini; Emilio Piccione
Journal:  Obstet Gynecol Sci       Date:  2016-05-13

9.  The use of misoprostol for cervical priming prior to hysteroscopy: a systematic review and analysis.

Authors:  Ying Hua; Wenwen Zhang; Xiaoli Hu; Ansu Yang; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2016-09-06       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.